A Call to Reclassify the Delta Hepatitis Virus as an Orphan Disease
Chronic infection with HDV is considered the most aggressive and severe form of viral hepatitis, associated with an increased risk of cirrhosis and liver cancer. Due to high morbidity and mortality, there is a clear need for additional therapies for this disease. The Food and Drug Administration (FDA)’s Office of Orphan Products Development should continue […]
English 
Spanish 
French 
Chinese 
Russian 
Arabic